BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 17182569)

  • 1. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin.
    Strauss L; Whiteside TL; Knights A; Bergmann C; Knuth A; Zippelius A
    J Immunol; 2007 Jan; 178(1):320-9. PubMed ID: 17182569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+ CD25- T cells.
    Kreijveld E; Koenen HJ; Hilbrands LB; van Hooff HJ; Joosten I
    Blood; 2007 Jan; 109(1):244-52. PubMed ID: 16902146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
    Yates J; Rovis F; Mitchell P; Afzali B; Tsang J; Garin M; Lechler RI; Lombardi G; Garden OA
    Int Immunol; 2007 Jun; 19(6):785-99. PubMed ID: 17545278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity.
    Stroopinsky D; Avivi I; Rowe JM; Avigan D; Katz T
    Eur J Immunol; 2009 Oct; 39(10):2703-15. PubMed ID: 19634189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
    Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
    J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.
    Allan SE; Crome SQ; Crellin NK; Passerini L; Steiner TS; Bacchetta R; Roncarolo MG; Levings MK
    Int Immunol; 2007 Apr; 19(4):345-54. PubMed ID: 17329235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans.
    Cavassani KA; Campanelli AP; Moreira AP; Vancim JO; Vitali LH; Mamede RC; Martinez R; Silva JS
    J Immunol; 2006 Nov; 177(9):5811-8. PubMed ID: 17056505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.
    Keever-Taylor CA; Browning MB; Johnson BD; Truitt RL; Bredeson CN; Behn B; Tsao A
    Cytotherapy; 2007; 9(2):144-57. PubMed ID: 17453966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
    Strauss L; Bergmann C; Whiteside TL
    Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
    Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL
    PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical-grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene.
    Guillot-Delost M; Cheraï M; Hamel Y; Rosenzwajg M; Baillou C; Simonin G; Leclercq V; Mariotti-Ferrandiz ME; Six A; Bon-Durand V; Maury S; Salomon BL; Cohen JL; Klatzmann D; Lemoine FM
    J Gene Med; 2008 Aug; 10(8):834-46. PubMed ID: 18615770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression.
    Ji J; Cloyd MW
    Int Immunol; 2009 Mar; 21(3):283-94. PubMed ID: 19208751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells.
    Li R; Perez N; Karumuthil-Melethil S; Prabhakar BS; Holterman MJ; Vasu C
    J Immunol; 2007 Oct; 179(8):5191-203. PubMed ID: 17911604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.